Positive phase III data unveiled for new GnRH blocker degarelix
-Data from a Phase III study presented at the 23rd Annual European Association of Urology Congress demonstrated that the investigational GnRH blocker, degarelix…
Ferring Pharmaceuticals submits new drug application for degarelix, a prostate cancer treatment
-Ferring Pharmaceuticals announced today that it has submitted applications in Europe and the United States for…
Launch of new, prestigious infertility and gynaecology research grant (FRIGGA) at “Update in Infertility 2008”
-Ferring Pharmaceuticals today launches the first Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) for fundamental fertility and gynaecology research…
Archives Press release 2008
Archives Press release 2008